144 related articles for article (PubMed ID: 6791883)
1. Comparison of nadolol, a new long-acting beta-receptor blocking agent, and placebo in the treatment of stable angina pectoris.
Shapiro W; Park J; DiBianco R; Singh SN; Katz RJ; Fletcher R
Chest; 1981 Oct; 80(4):425-30. PubMed ID: 6791883
[TBL] [Abstract][Full Text] [Related]
2. Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease.
Harris FJ; Low RI; Paumer L; Amsterdam EA; Mason DT
Am J Cardiol; 1983 Jan; 51(1):13-8. PubMed ID: 6129794
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of the effect of a selective and a nonselective beta receptor blocker on the ischemic ST segment, lung function and stress-induced decrease in blood glucose].
Brügmann U; Blasini R
Herz; 1986 Feb; 11(1):55-61. PubMed ID: 2870014
[TBL] [Abstract][Full Text] [Related]
4. Nadolol compared to propranolol for treating chronic stable angina pectoris.
Miller LA; Crawford MH; O'Rourke RA
Chest; 1984 Aug; 86(2):189-93. PubMed ID: 6146499
[TBL] [Abstract][Full Text] [Related]
5. Comparison of antianginal efficacy of one conventional and three long acting beta-adrenoreceptor blocking agents in stable angina pectoris.
Jones GR; Mir MA
Br Heart J; 1981 Nov; 46(5):503-7. PubMed ID: 6119104
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacodynamics of the new beta blockader corgard (nadolol) in patients with stress-induced angina pectoris].
Nikolenko SA; Metelitsa VI; Nazarenko VA; Martsevich SIu; Kulikova TV
Kardiologiia; 1984 Feb; 24(2):14-8. PubMed ID: 6143849
[TBL] [Abstract][Full Text] [Related]
7. A comparison of carteolol and nadolol in the treatment of stable angina pectoris.
Luther RR; Glassman HN; Jordan DC
J Clin Pharmacol; 1988 Jul; 28(7):634-9. PubMed ID: 3063728
[TBL] [Abstract][Full Text] [Related]
8. Comparison of celiprolol and propranolol in stable angina pectoris. Celiprolol International Angina Study Group.
Frishman WH; Heiman M; Soberman J; Greenberg S; Eff J
Am J Cardiol; 1991 Apr; 67(8):665-70. PubMed ID: 1672481
[TBL] [Abstract][Full Text] [Related]
9. Atenolol, nadolol, and pindolol in angina pectoris on effort: effect of pharmacokinetics.
Kostis JB; Lacy CR; Krieger SD; Cosgrove NM
Am Heart J; 1984 Oct; 108(4 Pt 2):1131-6. PubMed ID: 6148873
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the new beta-adrenoceptor antagonist, nadolol, and propranolol in the treatment of angina pectoris.
Furberg B; Dahlqvist A; Raak A; Wrege U
Curr Med Res Opin; 1978; 5(5):388-93. PubMed ID: 26520
[TBL] [Abstract][Full Text] [Related]
11. Comparison of bepridil with nadolol for angina pectoris.
Pflugfelder PW; Humen DP; O'Brien PA; Purves PD; Jablonsky G; Kostuk WJ
Am J Cardiol; 1987 Jun; 59(15):1283-8. PubMed ID: 3296724
[TBL] [Abstract][Full Text] [Related]
12. Duration of effects of isradipine during twice daily therapy in angina pectoris.
Thadani U; Chrysant S; Gorwit J; Giles T; Archer S; Iteld B; Singh S; Copen D; Wakeford C; Hobbs S
Cardiovasc Drugs Ther; 1994 Apr; 8(2):199-210. PubMed ID: 7918132
[TBL] [Abstract][Full Text] [Related]
13. Randomized double-blind study of pindolol in patients with stable angina pectoris.
Harston WE; Friesinger GC
Am Heart J; 1982 Aug; 104(2 Pt 2):504-11. PubMed ID: 7102537
[TBL] [Abstract][Full Text] [Related]
14. Atenolol: once-daily cardioselective beta blockade for angina pectoris.
Jackson G; Schwartz J; Kates RE; Winchester M; Harrison DC
Circulation; 1980 Mar; 61(3):555-60. PubMed ID: 6243518
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the duration of action of atenolol and nadolol for treatment of angina pectoris.
Kostis JB
Am J Cardiol; 1988 Dec; 62(17):1171-5. PubMed ID: 3057850
[TBL] [Abstract][Full Text] [Related]
16. Oral nitroglycerin as a prophylactic antianginal drug: clinical, physiologic, and statistical evidence of efficacy based on a three-phase experimental design.
Winsor T; Berger HJ
Am Heart J; 1975 Nov; 90(5):611-26. PubMed ID: 811102
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of bisoprolol in patients with stable angina pectoris: a preliminary report.
Kato K; Niitani H; Kanazawa T; Shimomura K; Toyama S
J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S154-9. PubMed ID: 2439788
[TBL] [Abstract][Full Text] [Related]
18. Celiprolol in the treatment of exercise induced angina pectoris.
Capone P; Mayol R
J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S135-7. PubMed ID: 2427844
[TBL] [Abstract][Full Text] [Related]
19. Effects of the cardioselective beta-blocker metoprolol in angina pectoris. A subacute study with exercise tests.
Keyriläinen O; Uustialo A
Ann Clin Res; 1975 Dec; 7(6):433-41. PubMed ID: 2092
[TBL] [Abstract][Full Text] [Related]
20. Angina pectoris: effective therapy once daily.
Prager G
J Int Med Res; 1979; 7(1):39-44. PubMed ID: 33863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
